Skip to content

The Application of MyotonPRO in the assessment of post-stroke spasticity

The Application of MyotonPRO in the assessment of post-stroke spasticity

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077317
Enrollment
Unknown
Registered
2023-11-06
Start date
2023-11-06
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spasticity

Interventions

Case series:No

Sponsors

Department of Rehabilitation Medicine,Shanghai Xuhui Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Voluntary participation, the subject can fully understand and cooperate and be willing to sign the consent form. If the subject is unable to sign the consent form due to hemiplegia, the legal guardian signs the informed consent form; (2) The first occurrence of stroke or previous lacunar infarction without sequelae; (3) Conform to the diagnosis of stroke in Diagnostic Points of Various Cerebrovascular Diseases adopted by the Fourth National Conference on Cerebrovascular Diseases in 1995, and showed a single infarction or hemorrhage on the side by CT or MRI. kitchen; (4) Unilateral hemiplegia, with at least one positive sign of upper motor neuron syndrome (tendon hyper-reflexes, spasm, co-contraction, combined response, and increased flexor reflex afferents); (5) The onset time of stroke was from 2 weeks to 12 mouths, Aged 18 to 80 years old, male or female, left or right, subjects with stable condition, clear consciousness, can tolerate sitting and standing for 5 mins;

Exclusion criteria

Exclusion criteria: 1. Patients who have Parkinson's disease and other high muscle tone; 2. Patients who have serious cognitive, verbal, visual, hearing or mental disorders and other effects of examination and treatment; 3. Patients who had a lacunar infarction and have sequelae; 4. Patients who have joint with disease (such as joint surgery or rheumatoid arthritis); 5.There are contraindications for surface electromyography or transcutaneous electrical nerve stimulation (such as epidermal damage, fever, etc.); 6.Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
frequency;triple spasticity scale;

Secondary

MeasureTime frame
H reflex;

Countries

China

Contacts

Public ContactLijun Zhen

Department of Rehabilitation Medicine,Shanghai Xuhui Central Hospital

zlj15153149@163.com+86 177 0162 8436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026